Comparative study of OROS-MPH and atomoxetine on executive function improvement in ADHD: a randomized controlled trial (Q50782551)

19 March 2018

title

Comparative study of OROS-MPH and atomoxetine on executive function improvement in ADHD: a randomized controlled trial (English)

1 reference

19 March 2018

1 reference

Li Yang

1

1 reference

19 March 2018

Qingjiu Cao

2

1 reference

19 March 2018

Lan Shuai

3

1 reference

19 March 2018

Haimei Li

4

1 reference

19 March 2018

Yufeng Wang

6

1 reference

19 March 2018

Raymond C. K. Chan

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:22017969

15 December 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=22017969

15 December 2024

publication date

21 October 2011

1 reference

19 March 2018

The International Journal of Neuropsychopharmacology

published in

1 reference

19 March 2018

volume

15

1 reference

19 March 2018

issue

1

1 reference

19 March 2018

page(s)

15-26

1 reference

19 March 2018

Alpha2A-adrenoceptor stimulation improves prefrontal cortical regulation of behavior through inhibition of cAMP signaling in aging animals

cites work

1 reference

https://api.crossref.org/works/10.1017/S1461145711001490

21 January 2018

1 reference

https://api.crossref.org/works/10.1017/S1461145711001490

21 January 2018

1 reference

https://api.crossref.org/works/10.1017/S1461145711001490

Neuropsychological and behavioral assessment of ADHD in seven- to twelve-year-old children: a discriminant analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017/S1461145711001490

Executive functions and developmental psychopathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1017/S1461145711001490

Medications do not necessarily normalize cognition in ADHD patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1017/S1461145711001490

The ADHD response-inhibition deficit as measured by the stop task: replication with DSM-IV combined type, extension, and qualification.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017/S1461145711001490

Atomoxetine in the treatment of children and adolescents with attention-deficit/hyperactivity disorder: a randomized, placebo-controlled, dose-response study

21 January 2018

1 reference

https://api.crossref.org/works/10.1017/S1461145711001490

Atomoxetine in adults with ADHD: two randomized, placebo-controlled studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1017/S1461145711001490

Atomoxetine and osmotically released methylphenidate for the treatment of attention deficit hyperactivity disorder: acute comparison and differential response.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017/S1461145711001490

Methylphenidate improves working memory and set-shifting in AD/HD: relationships to baseline memory capacity

21 January 2018

1 reference

https://api.crossref.org/works/10.1017/S1461145711001490

Atomoxetine and neuropsychological function in children with attention-deficit/hyperactivity disorder: results of a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1017/S1461145711001490

Magnetic Resonance Imaging Measurement of the Caudate Nucleus in Adolescents With Attention-Deficit Hyperactivity Disorder and Its Relationship With Neuropsychological and Behavioral Measures

21 January 2018

1 reference

https://api.crossref.org/works/10.1017/S1461145711001490

Local infusion of an alpha-1 adrenergic agonist into the prefrontal cortex impairs spatial working memory performance in monkeys.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017/S1461145711001490

Behavior ratings of executive function among preschoolers with ADHD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017/S1461145711001490

Alpha-2 adrenergic modulation of prefrontal cortical neuronal activity related to spatial working memory in monkeys

21 January 2018

1 reference

https://api.crossref.org/works/10.1017/S1461145711001490

Effect of methylphenidate on Stroop Color-Word task performance in children with attention deficit hyperactivity disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017/S1461145711001490

Once-daily atomoxetine treatment for children with attention-deficit/hyperactivity disorder, including an assessment of evening and morning behavior: a double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1017/S1461145711001490

Executive function and attention deficit hyperactivity disorder: stimulant medication and better executive function performance in children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017/S1461145711001490

Working memory in childhood-onset schizophrenia and attention-deficit/hyperactivity disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1017/S1461145711001490

Guanfacine, but not clonidine, improves planning and working memory performance in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1017/S1461145711001490

Methylphenidate improves aspects of executive function in African American children with ADHD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017/S1461145711001490

Neuropsychological outcome in adolescents/young adults with childhood ADHD: profiles of persisters, remitters and controls

21 January 2018

1 reference

https://api.crossref.org/works/10.1017/S1461145711001490

Cellular basis of working memory

21 January 2018

1 reference

https://api.crossref.org/works/10.1017/S1461145711001490

Modulation of memory fields by dopamine D1 receptors in prefrontal cortex.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017/S1461145711001490

Confirmatory factor analysis of the Behavior Rating Inventory of Executive Function (BRIEF) in a clinical sample

21 January 2018

1 reference

https://api.crossref.org/works/10.1017/S1461145711001490

An open study of adjunct OROS-methylphenidate in children and adolescents who are atomoxetine partial responders: I. Effectiveness

21 January 2018

1 reference

https://api.crossref.org/works/10.1017/S1461145711001490

Profiles of everyday executive function in acquired and developmental disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1017/S1461145711001490

How specific are executive functioning deficits in attention deficit hyperactivity disorder and autism?

21 January 2018

1 reference

https://api.crossref.org/works/10.1017/S1461145711001490

A randomized, placebo-controlled study of once-daily atomoxetine in the school setting in children with ADHD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017/S1461145711001490

Executive function in pediatric bipolar disorder and attention-deficit hyperactivity disorder: in search of distinct phenotypic profiles

21 January 2018

1 reference

https://api.crossref.org/works/10.1017/S1461145711001490

The relationship between parental report on the BRIEF and performance-based measures of executive function in children with moderate to severe traumatic brain injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1017/S1461145711001490

Inverted-U dopamine D1 receptor actions on prefrontal neurons engaged in working memory

21 January 2018

1 reference

https://api.crossref.org/works/10.1017/S1461145711001490

Improvement of executive functions in boys with attention deficit hyperactivity disorder: an open-label follow-up study with once-daily atomoxetine

21 January 2018

1 reference

https://api.crossref.org/works/10.1017/S1461145711001490

Neuronal mechanisms of executive control by the prefrontal cortex

21 January 2018

1 reference

https://api.crossref.org/works/10.1017/S1461145711001490

Atomoxetine and stroop task performance in adult attention-deficit/hyperactivity disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1017/S1461145711001490

Asymmetrical visual-spatial attentional performance in ADHD: Evidence for a right hemispheric deficit

21 January 2018

1 reference

https://api.crossref.org/works/10.1017/S1461145711001490

Reserpine impairs spatial working memory performance in monkeys: reversal by the alpha 2-adrenergic agonist clonidine

21 January 2018

1 reference

https://api.crossref.org/works/10.1017/S1461145711001490

Attention deficit hyperactivity disorder, combined type: better executive function performance with longer-term psychostimulant medication.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017/S1461145711001490

Executive function impairments in high IQ adults with ADHD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017/S1461145711001490

Neurocognitive effects of methylphenidate in adult attention-deficit/hyperactivity disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1017/S1461145711001490

The effects of prefrontal intracortical microinjections of an alpha-2 agonist, alpha-2 antagonist and lidocaine on the delayed alternation performance of aged rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1017/S1461145711001490

How well do measures of inhibition and other executive functions discriminate between children with ADHD and controls?

21 January 2018

1 reference

https://api.crossref.org/works/10.1017/S1461145711001490

Atomoxetine for the treatment of attention-deficit/hyperactivity disorder (ADHD) in children with ADHD and dyslexia

21 January 2018

1 reference

https://api.crossref.org/works/10.1017/S1461145711001490

Selective inhibition in children with attention-deficit hyperactivity disorder off and on stimulant medication

21 January 2018

1 reference

https://api.crossref.org/works/10.1017/S1461145711001490

Studies of interference in serial verbal reactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1017/S1461145711001490

Effectiveness and tolerability of tomoxetine in adults with attention deficit hyperactivity disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1017/S1461145711001490

Atomoxetine hydrochloride and executive function in children with attention-deficit/hyperactivity disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1017/S1461145711001490

Frontal lobe functions in attention deficit disorder with and without hyperactivity: a review and research report

21 January 2018

1 reference

https://api.crossref.org/works/10.1017/S1461145711001490

Predicting Impairment in Major Life Activities and Occupational Functioning in Hyperactive Children as Adults: Self-Reported Executive Function (EF) Deficits Versus EF Tests

21 January 2018

1 reference

https://api.crossref.org/works/10.1017/S1461145711001490

Methylphenidate improves response inhibition in adults with attention-deficit/hyperactivity disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1017/S1461145711001490

Alpha 2-adrenergic mechanisms in prefrontal cortex associated with cognitive decline in aged nonhuman primates

21 January 2018

1 reference

https://api.crossref.org/works/10.1017/S1461145711001490

Methylphenidate improves prefrontal cortical cognitive function through alpha2 adrenoceptor and dopamine D1 receptor actions: Relevance to therapeutic effects in Attention Deficit Hyperactivity Disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1017/S1461145711001490

An open-label, dose-ranging study of atomoxetine in children with attention deficit hyperactivity disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1017/S1461145711001490

Practice Parameter for the Assessment and Treatment of Children and Adolescents With Attention-Deficit/Hyperactivity Disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1017/S1461145711001490

Confirmation of an inhibitory control deficit in attention-deficit/hyperactivity disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017/S1461145711001490

Neuropsychological profiles of adolescents with ADHD: effects of reading difficulties and gender

21 January 2018

1 reference

https://api.crossref.org/works/10.1017/S1461145711001490

Methylphenidate restores visual memory, but not working memory function in attention deficit-hyperkinetic disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1017/S1461145711001490

Toward defining a neuropsychology of attention deficit-hyperactivity disorder: performance of children and adolescents from a large clinically referred sample.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017/S1461145711001490

Neuropsychological executive functions and DSM-IV ADHD subtypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1017/S1461145711001490

7 January 2021

Enhanced and impaired attentional performance after infusion of D1 dopaminergic receptor agents into rat prefrontal cortex

1 reference

https://api.crossref.org/works/10.1017/S1461145711001490

7 January 2021

Contrasting deficits on executive functions between ADHD and reading disabled children

1 reference

https://api.crossref.org/works/10.1017/S1461145711001490

7 January 2021

Supranormal Stimulation of D1Dopamine Receptors in the Rodent Prefrontal Cortex Impairs Spatial Working Memory Performance

1 reference

https://api.crossref.org/works/10.1017/S1461145711001490

7 January 2021

Results from 2 proof-of-concept, placebo-controlled studies of atomoxetine in children with attention-deficit/hyperactivity disorder.

1 reference

https://api.crossref.org/works/10.1017/S1461145711001490

7 January 2021

The alpha-2 adrenergic agonist guanfacine improves memory in aged monkeys without sedative or hypotensive side effects: evidence for alpha-2 receptor subtypes.

1 reference

https://api.crossref.org/works/10.1017/S1461145711001490

7 January 2021

Deficient inhibitory control in attention deficit hyperactivity disorder

1 reference

https://api.crossref.org/works/10.1017/S1461145711001490

7 January 2021

Attenuation of delay-period activity of monkey prefrontal neurons by an alpha2-adrenergic antagonist during an oculomotor delayed-response task

1 reference

https://api.crossref.org/works/10.1017/S1461145711001490

7 January 2021

Chinese Mental Health Journal

2

23

742

Qian

2009

1 reference

https://api.crossref.org/works/10.1017/S1461145711001490

15 December 2024

Acta Psychologica Sinica

28

19

291

Ji

1987

1 reference

https://api.crossref.org/works/10.1017/S1461145711001490

15 December 2024

Shanghai jingshen yixue

40

2

76

Wu

1984

1 reference

https://api.crossref.org/works/10.1017/S1461145711001490

15 December 2024

Identifiers

1 reference

19 March 2018

1 reference

19 March 2018